Lymphoma Coalition’s new 5-year strategic plan is a roadmap to strengthen our impact and advance a better future for everyone impacted by lymphoma, including chronic lymphocytic leukaemia (CLL). Grounded in our values of respect, integrity, and collaboration, the plan reaffirms our unwavering commitment to the voices of patients, care partners, and advocates around the world.
This plan enhances how Lymphoma Coalition collaborates with organisations globally to generate and provide trusted information, knowledge, and best practice that makes equitable care possible.


Strategic Vision:
2025–2030
Five Key Priorities:
- Influence policy to improve optimal care
- Deliver usable evidence & information that leads to action
- Develop exemplary patient opinion leaders and empower patient organisations to fulfil their missions
- Connect diverse stakeholders to collaboratively advance care
- Ensure impact globally, regionally and locally
While all five areas are interconnected, a critical focus remains on the Global Patient Survey on Lymphomas & CLL and other research initiatives. These efforts are essential for:
- Generating the evidence that fills critical gaps in information
- Driving the development of new and more effective treatments that meet patient expectations
- Improving patient outcomes and quality of life
Delivering Actionable Evidence
Our commitment to usable evidence means that Lymphoma Coalition will:
- Ensure every patient, care partner, care provider, and decision-maker has access to timely, credible, medically validated information
- Structure Patient Reported Outcomes (PROs) and Patient-Reported Experience Measures (PREMs) to reflect individual patient experiences and enable improved learnings on care, therapy impacts, and treatment outcomes
- Conduct research and provide evidence to support local efforts, inform clinical trials and practice, and improve quality of life for patients
- Enhance communication channels to effectively disseminate information and resources
This new strategic plan is a living document- one that will guide how we evolve, deepen collaboration, and ensure the global lymphoma community is working together as effectively as possible to improve care and outcomes.
Together, we can enable hope and create meaningful change for everyone impacted by lymphoma.